The United Kingdom is witnessing a noticeable surge in interest surrounding copyright substances. Beyond the common use of psilocybin and LSD, investigators and enthusiasts are increasingly delving into less-charted territories, particularly copyright and the relatively new cannabinoid, CBG compound. This burgeoning movement encompasses clinical tr